PLUS THERAPEUTICS INC PSTV 深 滬
已收盤 09-19 16:00:00 美东时间
0.4156
-0.015
-3.60%
華盛通- 最 高0.44
- 今 開0.4371
- 成交量 865.97万股
- 最 低 0.413
- 昨 收 0.4311
- 總市值 2119.50万
- 52周最高 2.3099
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 0.1634
- 委 比 42.42%
- 總股本 5099.85万
- 歷史最高 343.35
- 量 比 1.50
- 振 幅 6.26%
- 歷史最低 0.1634
- 每 手 1
- 風險率 0.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
09-19 09:18
D. Boral Capital Maintains Buy on Plus Therapeutics, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains Plus Therapeutics (NASDAQ:PSTV) with a Buy and maintains $5 price target.
09-18 19:57
Plus Therapeutics Announces Successful Accreditation and Certification for Its CNSide® Diagnostics Clinical Laboratory
CNSide Diagnostics, a subsidiary of Plus Therapeutics, Inc., has received a CLIA certification from the Centers for Medicare & Medicaid Services (CMS) for its Houston-based lab. This certification is a crucial step toward broad U.S. market release of the CNSide CSF Assay Platform, meeting federal and state regulatory requirements. It enables the company to pursue state licensure, secure insurance coverage, and expand payment coding, supporting th...
09-18 11:30
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company, announces its participation in the H.C. Wainwright 27th Annual Global Investment Conference set for September 8-10, 2025, at the Lotte New York Palace Hotel. Marc H. Hedrick, M.D., President and CEO of Plus Therapeutics, will engage in a fireside chat with Sean Lee, VP of Equity Research at H.C. Wainwright. The chat will be available on-demand starting September 5, 2...
09-02 20:15
Plus Therapeutics Secures Nasdaq Compliance Extension
Plus Therapeutics ( ($PSTV) ) has shared an update. On August 22, 2025, Plus Th...
08-26 18:58
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
Plus Therapeutics, Inc. announced that as of June 30, 2025, it achieved stockholders’ equity of $3 million, meeting the Nasdaq Listing Rule 5550(b)(1) requirement of a minimum $2.5 million. Previously, the company had failed to meet this rule as of March 31, 2025, leading to a delisting notice. However, it requested a hearing, which was granted, and subsequently received an extension to demonstrate compliance with certain conditions. The company ...
08-15 11:30
Plus Therapeutics Awaits Nasdaq Compliance Confirmation
Plus Therapeutics ( ($PSTV) ) has provided an update. On June 3, 2025, Plus The...
08-15 05:15
Plus Therapeutics Q2 EPS $(0.01) Beats $(0.18) Estimate, Sales $1.390M Miss $1.486M Estimate
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.18) by 94.44 percent. This is a 98.59 percent increase over losses of $(0.71) per share from
08-15 04:29
Plus Therapeutics shares are trading lower after the company filed a prospectus to offer 33 million shares.
Plus Therapeutics shares are trading lower after the company filed a prospectus...
08-13 22:46
Plus Therapeutics Granted Continued Nasdaq Listing
An announcement from Plus Therapeutics ( ($PSTV) ) is now available. On June 3,...
08-13 18:28
